Emerging nanopharmaceuticals.
暂无分享,去创建一个
Shaker A Mousa | S. Mousa | D. Bharali | Dhruba J Bharali | Willie E. Bawarski | Elena Chidlowsky | Willie E Bawarski | Elena Chidlowsky
[1] W. Cascio,et al. Quantum dot labeling of mesenchymal stem cells , 2007, Journal of nanobiotechnology.
[2] John T. James,et al. PULMONARY TOXICITY OF SIMULATED LUNAR AND MARTIAN DUSTS IN MICE: II. BIOMARKERS OF ACUTE RESPONSES AFTER INTRATRACHEAL INSTILLATION , 2002, Inhalation toxicology.
[3] R. Zhuo,et al. Dendrimer/DNA complexes encapsulated in a water soluble polymer and supported on fast degrading star poly(DL-lactide) for localized gene delivery. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[4] R. Müller,et al. Influence of high pressure homogenisation equipment on nanodispersions characteristics. , 2000, International journal of pharmaceutics.
[5] H. Fessi,et al. Scanning electron microscopy and atomic force microscopy imaging of solid lipid nanoparticles derived from amphiphilic cyclodextrins. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[6] F. Garbagnati,et al. Intraarterial chemotherapy with polyoxyethylated castor oil free paclitaxel, incorporated in albumin nanoparticles (ABI‐007) , 2001, Cancer.
[7] S. Bhatia,et al. Probing the Cytotoxicity Of Semiconductor Quantum Dots. , 2004, Nano letters.
[8] S. Mousa,et al. From Nutraceuticals to Pharmaceuticals to Nanopharmaceuticals: A Case Study in Angiogenesis Modulation During Oxidative Stress , 2007, Molecular biotechnology.
[9] J. James,et al. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90 days after intratracheal instillation. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.
[10] P. Couvreur,et al. Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles , 1992, Investigational New Drugs.
[11] Hisataka Kobayashi,et al. Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores. , 2003, Bioconjugate chemistry.
[12] W. Mark Saltzman,et al. Nanosystems for simultaneous imaging and drug delivery to T cells , 2007, The AAPS Journal.
[13] James M Tour,et al. Surface-rolling molecules. , 2006, Journal of the American Chemical Society.
[14] M. Zaworotko,et al. Para-acyl-calix-arene based solid lipid nanoparticles (SLNs): a detailed study of preparation and stability parameters. , 2003, International journal of pharmaceutics.
[15] Kazunori Kataoka,et al. Multifunctional polymeric micelles with folate-mediated cancer cell targeting and pH-triggered drug releasing properties for active intracellular drug delivery. , 2005, Molecular bioSystems.
[16] Sung Ju Cho,et al. Quantum dot-induced cell death involves Fas upregulation and lipid peroxidation in human neuroblastoma cells , 2007, Journal of nanobiotechnology.
[17] R. Langer,et al. Polymers for the sustained release of proteins and other macromolecules , 1976, Nature.
[18] R. Cavalli,et al. Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats. , 2000, Pharmacological research.
[19] Huibi Xu,et al. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. , 2007, International journal of pharmaceutics.
[20] Jason J. Han,et al. CdSe/CdS/SiO2 core/shell/shell nanoparticles. , 2007, Journal of nanoscience and nanotechnology.
[21] Mauro Ferrari,et al. Release of Biologically Functional Interferon-Alpha from a Nanochannel Delivery System , 2005, Biomedical microdevices.
[22] V. Poon,et al. In vitro cytotoxity of silver: implication for clinical wound care. , 2004, Burns : journal of the International Society for Burn Injuries.
[23] V. Torchilin. Targeted pharmaceutical nanocarriers for cancer therapy and imaging , 2007, The AAPS Journal.
[24] K. Kono,et al. Synthesis of polyamidoamine dendrimers having poly(ethylene glycol) grafts and their ability to encapsulate anticancer drugs. , 2000, Bioconjugate chemistry.
[25] Sung Ju Cho,et al. Unmodified cadmium telluride quantum dots induce reactive oxygen species formation leading to multiple organelle damage and cell death. , 2005, Chemistry & biology.
[26] J. Simon. Estradiol in micellar nanoparticles: the efficacy and safety of a novel transdermal drug-delivery technology in the management of moderate to severe vasomotor symptoms , 2006, Menopause.
[27] Wei Liang,et al. Improving penetration in tumors with nanoassemblies of phospholipids and doxorubicin. , 2007, Journal of the National Cancer Institute.
[28] T. Webb,et al. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.
[29] R K Jain,et al. Transport of molecules, particles, and cells in solid tumors. , 1999, Annual review of biomedical engineering.
[30] C. Schengrund,et al. Dendrimers and antivirals: a review. , 2005, Current drug targets. Infectious disorders.
[31] Y. Cai,et al. Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[32] T. Xu,et al. Dendrimer-based prodrugs: design, synthesis, screening and biological evaluation. , 2007, Combinatorial chemistry & high throughput screening.
[33] R. Pandey,et al. Oral solid lipid nanoparticle-based antitubercular chemotherapy. , 2005, Tuberculosis.
[34] Rainer H Müller,et al. Cosmetic applications for solid lipid nanoparticles (SLN). , 2003, International journal of pharmaceutics.
[35] M. Howarth,et al. Targeting quantum dots to surface proteins in living cells with biotin ligase. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[36] R. Cavalli,et al. Transmucosal transport of tobramycin incorporated in solid lipid nanoparticles (SLN) after duodenal administration to rats. Part II--tissue distribution. , 2001, Pharmacological research.
[37] D. Quintanar-Guerrero,et al. Design and evaluation of a self-adhesive naproxen-loaded film prepared from a nanoparticle dispersion. , 2006, Journal of nanoscience and nanotechnology.
[38] S. Nie,et al. In vivo cancer targeting and imaging with semiconductor quantum dots , 2004, Nature Biotechnology.
[39] Erkki Ruoslahti,et al. Targeted quantum dot conjugates for siRNA delivery. , 2007, Bioconjugate chemistry.
[40] Marie-Hélène Dufresne,et al. Block copolymer micelles: preparation, characterization and application in drug delivery. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[41] P. Baron,et al. Exposure to Carbon Nanotube Material: Assessment of Nanotube Cytotoxicity using Human Keratinocyte Cells , 2003, Journal of toxicology and environmental health. Part A.
[42] P. Lam,et al. In vitro cytotoxicity testing of a nanocrystalline silver dressing (Acticoat) on cultured keratinocytes , 2004, British journal of biomedical science.
[43] Afsaneh Lavasanifar,et al. Amphiphilic block copolymers for drug delivery. , 2003, Journal of pharmaceutical sciences.
[44] Masato Yasuhara,et al. Quantum Dots Targeted to the Assigned Organelle in Living Cells , 2004, Microbiology and immunology.
[45] C. Larabell,et al. Quantum dots as cellular probes. , 2005, Annual review of biomedical engineering.
[46] G. Kwon,et al. Polymeric micelles for delivery of poorly water-soluble compounds. , 2003, Critical reviews in therapeutic drug carrier systems.
[47] P C Lauterbur,et al. Dendrimer‐based metal chelates: A new class of magnetic resonance imaging contrast agents , 1994, Magnetic resonance in medicine.
[48] R. Müller,et al. Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization , 1994 .
[49] F. Szoka,et al. Chemical approaches to triggerable lipid vesicles for drug and gene delivery. , 2003, Accounts of chemical research.
[50] V. Venkateswarlu,et al. Pharmacokinetics, tissue distribution and bioavailability of clozapine solid lipid nanoparticles after intravenous and intraduodenal administration. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[51] W. Webb,et al. Water-Soluble Quantum Dots for Multiphoton Fluorescence Imaging in Vivo , 2003, Science.
[52] Michael Hawkins,et al. Comparative Preclinical and Clinical Pharmacokinetics of a Cremophor-Free, Nanoparticle Albumin-Bound Paclitaxel (ABI-007) and Paclitaxel Formulated in Cremophor (Taxol) , 2005, Clinical Cancer Research.
[53] N. Kaji,et al. Quantum Dots for Single Bio-Molecule Imaging , 2007, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.
[54] Lawrence E Murr,et al. Comparative in vitro cytotoxicity assessment of some manufacturednanoparticulate materials characterized by transmissionelectron microscopy , 2005 .
[55] T. Xu,et al. Design, synthesis and potent pharmaceutical applications of glycodendrimers: a mini review. , 2007, Current drug discovery technologies.
[56] Bernard Cabane,et al. Structures of Nanoparticles Prepared from Oil-in-Water Emulsions , 2004, Pharmaceutical Research.
[57] Michael S. Goldberg,et al. Nanostructured materials for applications in drug delivery and tissue engineering , 2007, Journal of biomaterials science. Polymer edition.
[58] James M. Hill,et al. Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis. , 2005, Advanced drug delivery reviews.
[59] J. Hastewell,et al. Peptide drug delivery: Colonic and rectal absorption , 1997 .
[60] P. Speiser,et al. Optimization of Spray-Dried and -Congealed Lipid Micropellets and Characterization of Their Surface Morphology by Scanning Electron Microscopy , 2004, Pharmaceutical Research.
[61] Steffen Hackbarth,et al. Long-term exposure to CdTe quantum dots causes functional impairments in live cells. , 2007, Langmuir : the ACS journal of surfaces and colloids.
[62] T. Xu,et al. Pharmaceutical applications of dendrimers: promising nanocarriers for drug delivery. , 2008, Frontiers in bioscience : a journal and virtual library.
[63] Mark Green,et al. Semiconductor quantum dots and free radical induced DNA nicking. , 2005, Chemical communications.
[64] R. Bawa. Patents and nanomedicine. , 2007, Nanomedicine.
[65] J. Benoit,et al. Development and characterization of solid lipid nanoparticles loaded with magnetite. , 2002, International journal of pharmaceutics.
[66] R. Cavalli,et al. Intravenous Administration to Rabbits of Non-stealth and Stealth Doxorubicin-loaded Solid Lipid Nanoparticles at Increasing Concentrations of Stealth Agent: Pharmacokinetics and Distribution of Doxorubicin in Brain and Other Tissues , 2002, Journal of drug targeting.
[67] Robert Langer,et al. Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer. , 2007, Nano letters.
[68] M. Brechbiel,et al. PAMAM dendrimer based macromolecules as improved contrast agents. , 2005, Molecular pharmaceutics.
[69] Robert Langer,et al. Small-scale systems for in vivo drug delivery , 2003, Nature Biotechnology.
[70] Bradford G Orr,et al. Direct observation of lipid bilayer disruption by poly(amidoamine) dendrimers. , 2004, Chemistry and physics of lipids.
[71] Robert Langer,et al. Smart Biomaterials , 2004, Science.